Vanguard Group Inc Isoray, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	4,566,356 Added 34.56%	17,780,106 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	N/A	395,124 Added 3.08%	13,213,750 $9.12 Million
Q3 2023 Nov 14, 2023	BUY	N/A	99,189 Added 0.78%	12,818,626 $8.84 Million
Q2 2023 Aug 14, 2023	BUY	$0.0 - $0.69 $0 - $496,789	719,985 Added 6.0%	12,719,437 $8.78 Million
Q1 2023 May 15, 2023	BUY	$0.0 - $0.67 $0 - $3.99 Million	5,948,654 Added 98.31%	11,999,452 $7.68 Million
Q4 2022 Feb 10, 2023	BUY	$0.24 - $0.4 $715 - $1,193	2,983 Added 0.05%	6,050,798 $1.45 Million
Q1 2022 May 13, 2022	SELL	$0.31 - $0.41 $5,696 - $7,534	-18,377 Reduced 0.3%	6,047,815 $2.2 Million
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.68 $20,640 - $36,935	-54,317 Reduced 0.89%	6,066,192 $2.35 Million
Q2 2021 Aug 13, 2021	BUY	$0.75 - $1.15 $4.59 Million - $7.04 Million	6,120,509 New	6,120,509 $4.88 Million

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.